You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

249 Results
Document
Guidelines and Advice
Oct 2023
The following information answers many of the questions primary care physicians commonly ask about the Screening Activity Report and the included...
A variety of screening tools and resources are available to support the screening activities of primary care providers, nurses and specialists.
Drug
Other Name(s): Sylvant®
Mar 2025
Regimen
Cancer Type:
Hematologic, 
Rare Diseases
Intent: Palliative
Funding:
New Drug Funding Program
    Siltuximab - Multicentric Castleman’s Disease (MCD)
Mar 2025

Pages